Destiny’s Chief Business Officer, Dr Stephanie Bewick, speaks to Labiotech about her role

Wednesday May 4, 2022

Destiny Pharma’s Chief Business Officer, Dr Stephanie Bewick, talks to @Labiotech-eu about her role, as part of the series ‘Chief Business Officers: Shedding Light on Biotech’s Dealmakers’.  To read the Labiotech article, click here